Skip to main content
    O

    OPTIMIZERx Corp (OPRX)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $8.85
    +0.56 (+6.76%)

    Market Cap: $156.15M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    72%(26/36)
    Avg Surprise
    +63.95%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.16
    Range$0.10 - $0.22
    5 analysts
    EPS RevisionsNo revisions (7d)
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$0.25-34.1%
    60d ago$0.25-34.1%
    30d ago$0.17-4.7%
    7d ago$0.17-4.7%
    Current$0.16
    Revenue Consensus
    $21M
    Range$21M - $22M
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.60
    Range$0.44 - $0.71
    5 analysts
    Revenue Consensus
    $36M
    Range$35M - $38M
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.60---
    Sep 26EST
    		-$0.16---
    Jun 26
    Reported Aug 12
    		$0.08$0.01+700.00%Beat-50.0%
    Mar 26
    Reported May 12
    		$0.00N/A-100.00%Miss-100.0%
    Dec 25
    Reported Mar 5
    		$0.51$0.22+131.82%Beat+264.3%
    Sep 25
    Reported Nov 6
    		$0.20$0.04+400.00%Beat+66.7%
    Jun 25
    Reported Aug 7
    		$0.16$-0.09+277.78%Beat+700.0%
    Mar 25
    Reported May 12
    		$0.08$-0.12+166.67%Beat+172.7%
    Dec 24
    Reported Mar 12
    		$0.14$0.10+40.00%Beat-46.2%
    Sep 24
    Reported Nov 13
    		$0.12$0.06+100.00%Beat+33.3%
    Jun 24
    Reported Aug 8
    		$0.02N/A+128.57%Beat+300.0%
    Mar 24
    Reported May 14
    		$-0.11$-0.10-10.00%Miss-22.2%
    Dec 23
    Reported Mar 28
    		$0.26$0.32-18.75%Miss+4.0%
    Sep 23
    Reported Nov 6
    		$0.09$0.04+125.00%Beat+28.6%
    Jun 23
    Reported Aug 14
    		$-0.01$-0.02+50.00%Beat-125.0%
    Mar 23
    Reported May 10
    		$-0.09$-0.08-12.50%Miss-800.0%
    Dec 22
    Reported Mar 8
    		$0.25$0.24+4.17%Beat+13.6%
    Sep 22
    Reported Nov 8
    		$0.07$0.04+75.00%Beat-22.2%
    Jun 22
    Reported Aug 9
    		$0.04N/A-55.56%Miss-60.0%
    Mar 22
    Reported May 4
    		$-0.01$-0.01+0.00%Beat-133.3%
    Dec 21
    Reported Feb 24
    		$0.22$0.21+4.76%Beat+37.5%
    Sep 21
    Reported Nov 9
    		$0.09$0.13-30.77%Miss+50.0%
    Jun 21
    Reported Aug 4
    		$0.10$0.07+42.86%Beat+400.0%
    Mar 21
    Reported May 6
    		$0.03$0.01+200.00%Beat+150.0%
    Dec 20
    Reported Feb 24
    		$0.16$0.16+0.00%Beat+633.3%
    Sep 20
    Reported Nov 9
    		$0.06$0.04+50.00%Beat+220.0%
    Jun 20
    Reported Aug 5
    		$0.02$-0.03+166.67%Beat-77.8%
    Mar 20
    Reported May 4
    		$-0.06$-0.03-100.00%Miss-200.0%
    Dec 19
    Reported Feb 27
    		$-0.03$0.01-400.00%Miss-200.0%
    Sep 19
    Reported Nov 5
    		$-0.05$0.08-162.50%Miss-171.4%
    Jun 19
    Reported Aug 7
    		$0.09$0.08+12.50%Beat+28.6%
    Mar 19
    Reported May 8
    		$0.06$0.02+200.00%Beat+100.0%
    Dec 18
    Reported Feb 26
    		$-0.01$-0.01+0.00%Beat+66.7%
    Sep 18
    Reported Nov 5
    		$0.07$0.06+16.67%Beat+275.0%
    Jun 18
    Reported Aug 7
    		$0.07$0.03+133.33%Beat+275.0%
    Mar 18
    Reported May 2
    		$0.03$-0.03+200.00%Beat+200.0%
    Dec 17
    Reported Feb 27
    		$-0.03$-0.03+0.00%Beat-50.0%
    Sep 17
    Reported Nov 2
    		$-0.04$-0.03-33.33%Miss-
    Jun 17
    Reported Aug 1
    		$-0.04N/AN/ABeat-
    Mar 17
    Reported May 3
    		$-0.03N/AN/ABeat-
    Dec 16
    Reported Mar 8
    		$-0.02$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio9.32EV/EBITDA9.74x
    Price/FCF9.15xFCF Yield10.92%
    Profitability
    Profit Margin4.66%Operating Margin-0.43%
    ROE3.68%ROIC5.03%
    Financial Health
    Debt/Equity0.15xInterest Coverage2.38x
    Current Ratio5.58xQuick Ratio5.58x
    Trading Statistics
    Beta1.26Avg Volume178.74K
    52-Week High$22.2552-Week Low$4.54

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$8.51
    SMA 20$8.20
    SMA 50$7.90
    SMA 200$7.52
    EMA 10$8.43
    EMA 20$8.26
    EMA 50$7.80
    EMA 200$8.22

    MACD

    Line: 0.24Signal: 0.23Hist: 0.00

    ADX

    ADX: 21.7+DI: 31.0-DI: 16.6

    Aroon & PSAR

    Aroon Up72.0
    Aroon DownN/A
    PSAR$9.12

    Bollinger Bands

    Upper Band$9.08
    Lower Band$7.32
    %B Position2157%(Upper)
    Band Width0.87

    RSI (14-Day)

    Neutral
    63.9

    Momentum Oscillators

    Stoch %K59.0
    Stoch %D53.6
    Williams %R-22.1
    ROC (10d)5.5%
    Momentum0.46
    CCI (20d)78.1
    MFI (14d)68.9

    Volatility Measures

    ATR (14d)$0.43(4.8%)
    StdDev (20d)0.44
    Hist Vol47.6%(High)

    Volume Flow

    VWAP$8.62
    OBV569.2K
    AD Line-4.2M
    CMF (20d)-0.040

    Volume Metrics

    Avg Vol (20d)190.1K
    Vol Ratio0.8x
    VWMA (20d)$8.17

    Pivot Points

    R3$8.77
    R2$8.64
    R1$8.47
    Pivot Point$8.34
    S1$8.17
    S2$8.04
    S3$7.87

    Advanced Oscillators

    TSI18.67
    Ultimate Osc49.8
    KST89.50

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$20.50M$19.84M$32.24M$26.07M$29.20M$21.93M$32.32M$21.31M$18.81M$19.69M$28.37M$16.33M
    Cost of Revenue$4.82M$4.91M$8.14M$8.55M$10.56M$8.58M$10.29M$7.86M$7.11M$7.49M$10.53M$6.53M
    Gross Profit$15.69M$14.93M$24.10M$17.52M$18.64M$13.34M$22.02M$13.45M$11.70M$12.20M$17.84M$9.80M
    Operating Expenses$15.78M$14.54M$15.53M$15.47M$15.43M$15.45M$18.39M$22.01M$15.45M$17.23M$26.64M$13.35M
    R&D$3.27M$3.40M$0$0$3.09M$3.25M$0$0$0$0$0$0
    SG&A$3.70M$3.51M$7.12M$14.39M$3.91M$4.56M$5.83M$13.43M$14.38M$16.17M$5.18M$12.89M
    Operating Income$-88,000$396,000$8.57M$2.05M$3.21M$-2,102,000$3.63M$-8,562,000$-3,749,000$-5,029,000$-10,937,000$-3,553,000
    Interest Income$81,000$77,000$84,000$91,000$90,000$88,000$96,000$107,000$106,000$20,000$118,000$688,000
    Interest Expense$1.13M$1.16M$1.24M$1.15M$1.60M$1.30M$1.56M$1.52M$1.53M$1.55M$836,000$0
    Income Before Tax$-1,096,000$-644,000$7.47M$1.05M$1.73M$-3,272,000$2.21M$-9,941,000$-5,096,000$-6,555,000$-11,773,000$-2,865,000
    Income Tax Expense$-393,000$-149,000$2.45M$270,000$199,000$-1,073,000$2.29M$-817,000$-1,088,000$344,000$-7,631,000$0
    Net Income$-703,000$-495,000$5.02M$779,000$1.53M$-2,199,000$-79,000$-9,124,000$-4,008,000$-6,899,000$-4,142,000$-2,865,000
    EBITDA$1.29M$1.86M$10.03M$3.37M$4.75M$-795,000$5.05M$-7,247,000$-2,418,000$-3,780,000$-9,719,000$-3,087,000
    EBIT$-50,000$434,000$8.63M$2.11M$3.24M$-2,063,000$3.67M$-8,524,000$-3,674,000$-5,029,000$-10,937,000$-3,553,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OPRX

    News

    OptimizeRx stock expands access to 800,000 providers remains below its yearly high lacks? no

    OptimizeRx (OPRX) stock was trading at $8.64 on October 5, 2026, despite its OpenPath network expanding access to 800,000 healthcare professionals. The company reported a significant Q2 revenue decline of 29.8%...

    AD HOC NEWS•10/5/26•Neutral

    Form 4 OPTIMIZERx Corp For: 2 October By Investing.com

    This article announces the Form 4 filing for OPTIMIZERx Corp on October 2nd. The content is brief, primarily serving as an announcement for this regulatory filing...

    Investing.com UK•10/2/26•Neutral

    Form 4 OPTIMIZERx Corp For: 2 October By Investing.com

    This article announces the filing of Form 4 for OPTIMIZERx Corp on October 2, 2026. Form 4 is a U.S. Securities and Exchange Commission filing used to disclose changes in beneficial ownership of a company's securities by...

    Investing.com Canada•10/2/26•Neutral

    Stock vesting triggers tax withholding at OptimizeRx (OPRX): 414 shares at $8.39 each.

    OptimizeRx's Chief Business Officer, Andrew J. D'Silva, had 414 shares withheld on October 1, 2026, to cover tax withholding obligations upon the vesting of restricted stock units. Each share was valued at $8.39...

    Stock Titan•10/2/26•Neutral

    Learn Why The Bull Case For Trade Desk Stock Could Change Following Healthcare Ad Access Expansion

    The Trade Desk (TTD) recently integrated with OptimizeRx’s OpenPath, allowing advertisers programmatic access to healthcare point-of-care inventory across 400+ EHR systems...

    Simply Wall Street•10/2/26•Somewhat-Bullish

    OPRX Valuation and Fair Value

    P/E
    9.3x
    Forward P/E
    5.6x
    EV/EBITDA
    9.7x
    P/FCF
    9.2x
    PEG
    1.6x
    P/B
    1.3x
    See GNG's fair value

    OPRX Profitability: Margins, ROIC and FCF

    Gross margin
    73.2%
    Operating margin
    -0.4%
    Net margin
    4.7%
    ROIC
    5.0%
    ROE
    3.7%
    FCF margin
    18.4%
    FCF yield
    10.9%

    OPRX Competitors

    CompanyTicker
    Anbio Biotechnology Class A Ordinary SharesNNNN
    Mediwound LtdMDWD
    Compass Therapeutics Inc.CMPX
    Helius Medical Technologies Inc Class AHSDT
    Quipt Home Medical CorpQIPT
    JIN MEDICAL INTERNATIONAL LTD. Ordinary SharesZJYL
    Journey Medical CorpDERM
    Mersana Therapeutics IncMRSN

    Sector: Healthcare

    OPRX Analyst Ratings

    Consensus
    Buy
    Analysts
    6
    Strong Buy
    1
    Buy
    5
    Hold
    0
    Sell
    0
    Strong Sell
    0

    OPRX Bull Case vs Bear Case

    Bull case

    • OPRX converts 18.4% of revenue into free cash flow.
    • OPRX beat EPS estimates in 87.5% of its last 8 reported quarters.
    • 100.0% of OPRX's analyst ratings are Buy or Strong Buy.

    Bear case

    • OPRX's quarterly revenue changed -29.8% year over year.

    OPRX Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    214.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.16
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 3 down

    Frequently Asked Questions About OPRX

    Does OPRX pay dividends?

    OPTIMIZERx Corp (OPRX) does not currently pay a regular dividend.

    What is OPRX's P/E ratio?

    OPTIMIZERx Corp has a price-to-earnings (P/E) ratio of 9.32.

    What is OPRX's market cap?

    OPTIMIZERx Corp (OPRX) has a market capitalization of $156.15M with a current stock price of $8.85.

    Related stocks

    Sector: Healthcare

    All stocks starting with O

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In